LifeStance Health Group, Inc. (LFST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '20: 102M Q4 '20: 118.1M Q1 '21: 143.1M Q2 '21: 160.5M Q3 '21: 173.8M Q4 '21: 190M Q1 '22: 203.1M Q2 '22: 209.5M Q3 '22: 217.6M Q4 '22: 229.4M Q1 '23: 252.6M Q2 '23: 259.6M Q3 '23: 262.9M Q4 '23: 280.6M Q1 '24: 300.4M Q2 '24: 312.3M Q3 '24: 312.7M Q4 '24: 325.5M Q1 '25: 333M Q2 '25: 345.3M Q3 '25: 363.8M Q4 '25: 382.2M Q1 '26: 403.5M Q2 '26: 435.4M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '20: 2.7M Q4 '20: 3.9M Q1 '21: -881K Q2 '21: -47M Q3 '21: -124.7M Q4 '21: -113.8M Q1 '22: -64.9M Q2 '22: -60.5M Q3 '22: -38.8M Q4 '22: -46M Q1 '23: -34.1M Q2 '23: -48.4M Q3 '23: -74.4M Q4 '23: -32.3M Q1 '24: -16.8M Q2 '24: -15.9M Q3 '24: 47K Q4 '24: 1.1M Q1 '25: 1.6M Q2 '25: -3M Q3 '25: 7.4M Q4 '25: 18.1M Q1 '26: 22.3M Q2 '26: 30.7M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '20: -3.3M Q4 '20: -5.5M Q1 '21: -8.7M Q2 '21: -70M Q3 '21: -120.5M Q4 '21: -108M Q1 '22: -62.3M Q2 '22: -68.7M Q3 '22: -37.9M Q4 '22: -46.7M Q1 '23: -34.2M Q2 '23: -45.5M Q3 '23: -61.6M Q4 '23: -45M Q1 '24: -21.1M Q2 '24: -23.3M Q3 '24: 709K Q4 '24: -7.1M Q1 '25: 709K Q2 '25: -3.8M Q3 '25: 1.1M Q4 '25: 11.7M Q1 '26: 14.2M Q2 '26: 23.6M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-35M 0 35M 70M 105M Q3 '20: 11.2M Q4 '20: 4.2M Q1 '21: 9.9M Q2 '21: -16.9M Q3 '21: -14.2M Q4 '21: 30.6M Q1 '22: 3.3M Q2 '22: 7.8M Q3 '22: 5.7M Q4 '22: 35.9M Q1 '23: -7.9M Q2 '23: -434K Q3 '23: -25.4M Q4 '23: 16.8M Q1 '24: -21.8M Q2 '24: 44.1M Q3 '24: 22.7M Q4 '24: 62.3M Q1 '25: -3.1M Q2 '25: 64.4M Q3 '25: 27.3M Q4 '25: 57.6M Q1 '26: 33.1M Q2 '26: 99.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-60M -30M 0 30M 60M 90M Q3 '20: 1.7M Q4 '20: -6.4M Q1 '21: -1.2M Q2 '21: -37.6M Q3 '21: -38.2M Q4 '21: -8M Q1 '22: -24.6M Q2 '22: -18M Q3 '22: -9.4M Q4 '22: 25.5M Q1 '23: -15.6M Q2 '23: -12M Q3 '23: -35.2M Q4 '23: 5.4M Q1 '24: -26.9M Q2 '24: 39M Q3 '24: 17.7M Q4 '24: 56M Q1 '25: -10.3M Q2 '25: 56.6M Q3 '25: 17M Q4 '25: 46.6M Q1 '26: 22.3M Q2 '26: 87.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '21: 313.5K Q3 '21: 343.4K Q1 '22: 350.8K Q2 '22: 353.7K Q3 '22: 357.5K Q1 '23: 360.9M Q2 '23: 363.2M Q3 '23: 372.5M Q1 '24: 376.3M Q2 '24: 379.4M Q3 '24: 380.4M Q1 '25: 390.7M Q2 '25: 386.7M Q3 '25: 388.9M Q1 '26: 395.1M Q2 '26: 387.3M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.